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Abstract
Background Folic acid use in the periconceptional period
reduces the risk of neural tube defects (NTDs). However,
applying this knowledge in daily practice is not an easy task.
We report here the current level of folic acid use in the
Netherlands and discuss the figures within the framework of
a national governmental campaign held in 1995 promoting
the use of folic acid and the professional interventions
undertaken since then.
Methods We carried out six studies in the northern Nether-
lands during 1995, 1996, 1998, 2000, 2003 and 2005,
respectively. The same methodology in the same health
professionals’ practices was followed in all studies. Pregnant
women attending their first or second antenatal visit were
asked to fill in a questionnaire aimed at assessing their
awareness and use of folic acid.
Results In 2005, most of the pregnant women used folic
acid “at some time in their pregnancy”, and 51% used it for
the entire advised period. Prior knowledge on the protective
affect of folic acid and on the period of use was strongly
related to the level of education. The use of folic acid in a
previous pregnancy [odds ratio (OR) 3.9, 95% confidence
interval (95% CI) 1.6–9.9], the use of an oral contraceptive
(OR 2.1, 95% CI 1.1–4.1) and parity (OR 0.08, 95% CI
0.01–0.5) significantly predicted the current correct use.
The most recent figures revealed that there is still a large
gap between more highly and less educated women in
terms of taking folic acid in the advised period: 63 versus
31%, respectively.
Discussion The aim of the Dutch Ministry of Health is to
have 70% of Dutch women wanting to become pregnant
use folic acid supplements in the advised period by 2010.
While this level has almost been reached among more
highly educated women (63%), it will take a great deal
more effort, money and creativity to achieve the necessary
increase from the current level of 31% among women with
a lower educational background.
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Background
An increased intake of folic acid in the periconceptional
period reduces the risk of neural tube defects (NTDs) by at
least 50% [1]. There are two standard strategies to achieve
periconceptional intake of folic acid: fortification of staple
foods with folic acid and/or health education initiatives
aimed at increasing the awareness of the target population
to the importance of taking folic acid supplements.
However, recent studies have shown that translating this
knowledge into prevention is not easy [2, 3]. The current
recommendation of taking 400 μg of folic acid periconcep-
tionally has been found not to be the optimal approach, and
although the prevalence of NTDs has now declined
substantially in the northern part of the Netherlands, it has
remained at about the same level across Europe in general.
The results of these studies clearly suggest that only a
public health policy that includes folic acid fortification of
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of NTDs. Since, in the short term, many European countries
are not expected to adopt such a fortification policy,
alternative strategies encouraging the taking of supplements
need to be developed and implemented.
We report here the latest figures on the use of folic acid
in the Netherlands. The situation in the Netherlands is
interesting because of the high percentage of planned
pregnancies – close to 80% of all pregnancies – and staple
foods are not fortified with folic acid. The aim of the
Ministry of Health is to have 70% of women use folic acid
supplements in the periconceptional period by 2010. A
government-sponsored mass media campaign was held in
1995 to promote the use of folic acid supplements by
women planning a pregnancy. Data from the northern part
of the Netherlands show that after this campaign there was
a 43% [95% confidence interval (95% CI) 15–61%]
reduction in the total prevalence of NTDs (from 11.44 per
10,000 births in 1989–1991 to 6.52 per 10,000 in 2000–
2002) [4]. In addition, since 2004, Dutch pharmacies have
been carrying out an ongoing proactive intervention aimed
at informing and motivating women using oral contra-
ceptives to start taking folic acid supplements “before
conception”. A pilot study showed that women who were
given this information by their pharmacy used folic acid
significantly more often than those who were not given any
information. Among women planning their first pregnancy
folic acid use was 62.5% in the intervention group versus
30.8% in the reference group [5].
We describe here what has happened to folic acid intake
in the Netherlands since the national campaign in 1995 and
the professional interventions undertaken since then.
Methods and subjects
We carried out six studies in northern Netherlands during
1995, 1996, 1998, 2000, 2003 and 2005, respectively [6–8].
The same methodology in the same health professionals’
practices was followed in all studies. The obstetric depart-
ments of three hospitals and seven midwives’ practices
participated in all of the surveys. Pregnant women attending
their first or second antenatal visit were asked to fill in a
questionnaire. Responses to our surveys varied between
75–90% and there was no temporal trend.
The questionnaire covered the awareness of the respond-
ents to the use of folic acid and current use (open-ended
questions for measuring qualitative knowledge) and demo-
graphics. In previous surveys, one of our focal points was
educational level since this was found to be an important
predictor of compliance with the advised use of folic acid.
The highest completed level of education was taken as an
indicator of socio-economic status (SES). In total there
were seven levels of education, ranging from elementary
school to university. For statistical analysis, the levels were
merged into low (levels 1–3), middle (4–5) and high (6–7)
education. The methodology has been described elsewhere
[9, 10]. Data were analysed using SPSS ver. 14 for
Windows (SPSS, Chicago, Ill.), and logistic regression
was used to calculate multivariate odds ratios (OR).
Results
For the 2005 survey, the mean results for all respondents
and in relation to how long they used folic acid are
presented in Table 1.
Knowledge
The most recent data from 2005 showed that of the 448
respondents, 95% (n=425) had heard about folic acid and
89% (n=397) had heard about folic acid before their
pregnancy (see Table 1). In total, 78% (n=347) had planned
their pregnancy, while for 16% (n=73) the pregnancy was
unplanned but welcomed, and for 6% (n=27) it was
unplanned. Seventy-three percent (n=328) knew about the
protective effect of folic acid for NTDs and 32% (n=143)
knew the entire advised period (4 weeks before conception
to 8 weeks after). All of these aspects were related to the
respondent’s level of education.
Of the women who had heard about folic acid (n=425),
66% (n=282) said the media were their most important
source of information. Medical professionals were men-
tioned as a second source by 240 respondents (57%). One
specific source in the Netherlands is the pharmacist: some
pharmacists put a sticker on the box of oral contraceptives
advising women to take folic acid if they stop taking the
pill, and this source was mentioned by 15% of the
respondents (n=62). Another action undertaken by phar-
macists is the distribution of a leaflet on folic acid. All
together, pharmacists were mentioned by 26% (n=110) of
the respondents.
Use
In 2005, 80% (n=348) of respondents used folic acid at
some time during the advised period, while 51% (n=222)
used it during the entire advised period.
More highly educated women used folic acid signifi-
cantly more often in the advised period (63%) than less
educated women (31%) in 2005 (see Fig. 1). Other
indicators for use in the advised period were parity,
qualitative knowledge about folic acid, the media as a
source of information and the age of the mother. Taking
oral contraceptives was also a significant predictor for
540 Eur J Clin Pharmacol (2008) 64:539–543taking folic acid in the advised period (p=0.004), whereas
other contraceptives, such as condoms, were not. Of the
women who had taken oral contraceptives before their
pregnancy, 68% used folic acid in the advised period. In
particular, 80% of all childless respondents who had taken
oral contraceptives used folic acid in the advised period;
this figure was 53% among women with one or more
children (p<0.001) who had used oral contraceptives.
For folic acid to be used in the advised period it is
imperative the pregnancy is planned and that the woman is
aware of folic acid before the pregnancy. This latter
variable was found to be highly associated with the level
of education (OR 22.4, 95% CI 6.8–77.7). In the 2005
study, 321 (71.8%) women planned their pregnancy and
knew about folic acid before getting pregnant. We tested
our data in a univariate approach to determine which
variables were significant in terms of folic acid use as
advised (see Table 1). When these variables were used in
the multivariate analysis, taking folic acid in a previous
pregnancy (OR 3.9, 95% CI 1.6–9.9), use of an oral
contraceptive (OR 2.1, 95% CI 1.1–4.1) and parity (OR
0.08, 95% CI: 0.01–0.5) were found to be the most
Table 1 Distribution of variables related to the use of folic acid among pregnant women in 2005
Variables Total (n=
448)
a
No folic acid
taken (n=87)
Folic acid taken in only
part of advised period
(n=126)
Folic acid taken in
advised period
(n=222)
p value
n % n % n % n %
Planned pregnancy 347 78% 52 15% 79 23% 206 61% <0.001
Use of contraceptives
Use of oral contraceptives 218 63% 24 11% 45 21% 144 68% 0.004
Use of other contraceptives 76 22% 10 14% 20 27% 43 59% 0.64
Heard of folic acid
Not heard of it 23 5% 23 100% 0 0% 0 0%
During pregnancy 28 6% 10 38% 16 62% 0 0%
Before pregnancy 397 89% 54 14% 110 28% 222 58% <0.001
Protective effect known 328 73% 42 13% 97 30% 180 56% 0.17
Know the right period for use 143 32% 14 10% 40 29% 85 61% 0.05
Sources of information
Media 282 66% 32 12% 79 29% 163 60% 0.01
Newspapers and journals 200 47% 25 13% 54 27% 118 60% 0.06
Books 111 26% 8 8% 30 28% 69 65% 0.01
Internet 109 26% 8 8% 37 35% 62 58% 0.03
Radio/TV 17 4% 2 13% 4 25% 10 63% 0.78
Professional 240 57% 32 14% 76 33% 123 53% 0.38
General Practitioner 118 28% 17 15% 40 35% 56 50% 0.42
Midwife 78 18% 9 12% 29 38% 38 55% 0.24
Gynaecologist 40 9% 5 13% 12 32% 21 55% 0.91
Pharmacist 110 26% 15 14% 29 27% 63 59% 0.11
Family 193 45% 29 16% 52 28% 106 57% 0.51
Age (years)
<20 9 2% 6 86% 1 14% 0 0%
20–24 48 11% 15 32% 15 32% 17 36%
25–29 142 32% 21 15% 41 30% 77 55%
30–34 151 34% 25 17% 44 30% 77 53%
>34 95 21% 19 20% 25 27% 49 53% <0.001
Education level
Low 76 17% 29 40% 21 29% 22 31%
Middle 210 47% 42 21% 61 30% 100 49%
High 158 36% 14 9% 44 28% 98 63% <0.001
Parity
No previous children 213 48% 34 16% 60 29% 114 55%
One previous child 178 40% 31 18% 52 30% 88 52%
More than one previous child 57 13% 22 39% 14 25% 20 36% 0.003
Used folic acid in a previous pregnancy 207 78% 21 10% 59 30% 119 60% <0.001
aThe total in the other three columns does not add up to 448 because of 13 missing data points
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acid in a previous pregnancy included by definition only
multigravida, we also analysed the data for nulligravida (n=
117) under the same conditions; However, for these
women, the use of oral contraceptives (OR 3.9, 95% CI
1.2–12.4) proved to be the only significant factor.
Discussion
In 2005, a large majority of pregnant women in the
northern Netherlands used folic acid “at some time in their
pregnancy” and 51% used it for the entire advised period.
The Dutch policy of advising women who want to become
pregnant to start with folic acid before conception has
therefore been reasonably successful. However, based on
the results of this study, there is still a great deal to be
achieved in terms of public health: (1) although the
majority of respondents knew about the beneficial effects
of folic acid, its use in the advised period was not
guaranteed, and (2) there is still a large gap between
women of different educational levels in terms of folic acid
use. Our data clearly reveals that the gap between women
of differing educational levels with respect to their use of
folic acid has been growing over the years and that this
difference is due to a difference in knowledge. Once
women with less education were aware of folic acid, they
took it as much as women with more education.
The uptake of folic acid in the Netherlands is higher than
in several other countries (see the summary by Ray et al.
[11]). A Dutch survey in 1994 showed that 27% of the
pregnant women were aware of the beneficial effects of
folic acid, 7.8% took it at some time during the pregnancy
and 0.4% took it in the recommended period [12]. The
national public health campaign in 1995 resulted in an
increased use of folic acid (Fig. 1). In 2005, however, a
substantial proportion of women still lacked sufficient
knowledge on the protective effect of folic acid and the
correct period of use. This latter fact may explain why
approximately 30% of the women took folic acid but only
during part of the recommended period. For this group,
preconceptional counselling could be an effective strategy
to improve the correct use of folic acid.
A sustained effect from a one-off media campaign (like
the government-sponsored folic acid campaign of 1995 in
the Netherlands) cannot be expected. In contrast, proactive
approaches that offer person-to-person counselling before
pregnancy and provide dietary supplements to the target
group have proved to be successful in China and in a
physician-intervention in Arkansas (USA) [13]. Health
providers, particularly gynaecologists and general practi-
tioners, can also play an important role in informing and
stimulating women planning a pregnancy to take folic acid.
The role of these professionals was indeed the strongest
predictor of folic acid use in an American study by De
Jong-van den Berg [14]. However, in daily practice, these
health providers often do not reach women before they
attempt to get pregnant. Because approximately 70% of
Dutch women take oral contraceptives before their first
pregnancy and therefore visit their pharmacy regularly,
Dutch pharmacists undertook a proactive intervention
aimed at informing and motivating women taking oral
contraceptives to start taking folic acid supplements before
becoming pregnant. This was accomplished by means of a
sticker on the oral contraceptives package, with the text
“Want a baby? Ask about folic acid at your pharmacy”,
and by providing a brochure with more detailed information
about folic acid. Our data indeed shows that among the
Fig. 1 Surveys in the northern Netherlands showing the use of folic acid in the advised period according to level of education, 1995–2005
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pregnancy, 68% had taken folic acid in the advised period
and that this was not influenced by their level of education.
This figure demonstrates that the information provided by
the pharmacists was successful, and this study shows that
the pharmacy deserves a structural place in the Dutch health
care system for communicating the message of starting with
folic acid before conception.
Since fortification of a staple food is not to be expected
in the short term in the Netherlands, strategies to promote
the taking of supplements should be developed and
implemented. In a recent review, Eichholzer pleaded for
creative, structural public health approaches towards pre-
venting NTDs in countries where mandatory food fortifi-
cation is not allowed [15]. We agree with this plea and
conclude that is important to emphasize the distribution of
knowledge on the correct period to take folic acid and to
have trustworthy and well-known people as ‘godmothers’
of promotion campaigns. Placing the folic acid message
into popular TV soap series in the Netherlands may also
have a positive effect, especially on women with a lower
educational level.
Our study also revealed another group worth focussing
on: women with two or more children who did not use folic
acid in their previous pregnancies are very unlikely to be
taking folic acid in their current pregnancy. Doctors in baby
clinics could play an important role in providing such
information because Dutch mothers visit such a clinic an
average of ten times after the birth of a child.
The aim of the Dutch Ministry of Health is to have 70%
of Dutch women wanting to become pregnant use folic acid
supplements in the advised period by 2010. This target has
almost been reached among the more highly educated
women (63%), but it will take much more effort, money
and creativity to increase the current level of 31% among
women with a lower educational level.
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